Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 26 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.12 Insider Own3.78% Shs Outstand263.79M Perf Week-1.92%
Market Cap965.06M Forward P/E40.53 EPS next Y0.09 Insider Trans-2.29% Shs Float259.38M Perf Month4.07%
Income-31.29M PEG- EPS next Q0.00 Inst Own49.60% Short Float13.49% Perf Quarter-1.92%
Sales176.55M P/S5.47 EPS this Y86.76% Inst Trans8.30% Short Ratio13.68 Perf Half Y-25.10%
Book/sh-0.93 P/B- EPS next Y296.30% ROA-10.19% Short Interest34.99M Perf Year-31.42%
Cash/sh0.52 P/C6.84 EPS next 5Y35.60% ROE- 52W Range3.17 - 5.75 Perf YTD-1.65%
Dividend Est.- P/FCF- EPS past 5Y21.35% ROI-31.25% 52W High-37.74% Beta1.23
Dividend TTM- Quick Ratio2.06 Sales past 5Y44.42% Gross Margin65.55% 52W Low12.93% ATR (14)0.15
Dividend Ex-Date- Current Ratio2.34 EPS Y/Y TTM69.17% Oper. Margin-5.30% RSI (14)52.28 Volatility2.84% 4.19%
Employees395 Debt/Eq- Sales Y/Y TTM131.61% Profit Margin-17.72% Recom1.33 Target Price6.92
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q111.49% Payout- Rel Volume0.68 Prev Close3.55
Sales Surprise1.03% EPS Surprise160.24% Sales Q/Q56.14% EarningsFeb 27 AMC Avg Volume2.56M Price3.58
SMA202.64% SMA500.77% SMA200-11.81% Trades Volume1,729,178 Change0.85%
Date Action Analyst Rating Change Price Target Change
Oct-10-23Initiated Wedbush Outperform $10
May-14-21Initiated RBC Capital Mkts Sector Perform $5
Dec-24-19Initiated Oppenheimer Outperform $2.50
Oct-25-19Initiated Cantor Fitzgerald Overweight $3
May-14-19Initiated BTIG Research Buy $3
Mar-04-19Initiated SVB Leerink Outperform $3
Feb-22-19Initiated SVB Leerink Outperform $3
Feb-28-18Downgrade Maxim Group Hold → Sell $1
Nov-01-17Downgrade Maxim Group Buy → Hold
Oct-10-17Initiated H.C. Wainwright Buy $7
Feb-20-24 06:00AM
Feb-15-24 06:05AM
Feb-12-24 12:30PM
Jan-25-24 05:29PM
Jan-02-24 06:05AM
06:00AM Loading…
Dec-28-23 06:00AM
Dec-16-23 09:01PM
Nov-08-23 03:27PM
Nov-07-23 09:15PM
Nov-06-23 06:15AM
Nov-01-23 10:01AM
Oct-31-23 04:00PM
06:15AM Loading…
Oct-30-23 06:15AM
Sep-07-23 07:08AM
Sep-05-23 06:00AM
Aug-28-23 06:30PM
Aug-14-23 12:44PM
Aug-08-23 05:16PM
Aug-07-23 06:00PM
Aug-01-23 06:00AM
Jul-31-23 04:00PM
Jul-13-23 07:31AM
07:00AM Loading…
Jun-22-23 06:05AM
Jun-11-23 08:05AM
May-28-23 07:49PM
May-24-23 08:30AM
May-23-23 09:50AM
May-10-23 12:02PM
May-09-23 11:30PM
May-02-23 05:00PM
Mar-27-23 04:05PM
Mar-14-23 02:26PM
Mar-07-23 05:00PM
Feb-24-23 01:30AM
Feb-23-23 04:00PM
Feb-22-23 06:05AM
Feb-16-23 05:00PM
Feb-15-23 12:46PM
Feb-10-23 05:00PM
Feb-09-23 08:50AM
Jan-24-23 06:00AM
Jan-23-23 06:05AM
Jan-18-23 08:00AM
Jan-17-23 06:36AM
Jan-05-23 06:00AM
Dec-31-22 07:11AM
Dec-06-22 09:55AM
Nov-30-22 12:29PM
Nov-10-22 06:05AM
Nov-08-22 04:30PM
Nov-01-22 06:00AM
Sep-29-22 11:38AM
Sep-21-22 05:00PM
Sep-19-22 06:00AM
Sep-08-22 01:18PM
Sep-06-22 06:15AM
Sep-01-22 06:00AM
Aug-25-22 09:09AM
Aug-19-22 06:18AM
Aug-16-22 09:03AM
Aug-10-22 07:19AM
Aug-09-22 05:15PM
Aug-02-22 06:00AM
Aug-01-22 07:35PM
Jul-26-22 10:13AM
Jun-20-22 09:28AM
Jun-03-22 10:00AM
May-25-22 10:16AM
May-24-22 06:00AM
May-19-22 06:00AM
May-17-22 06:06AM
May-09-22 06:00AM
May-06-22 01:30AM
May-05-22 05:25PM
May-04-22 06:15PM
MannKind Corp. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic products and devices for those with endocrine and orphan lung diseases. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Castagna MichaelChief Executive OfficerDec 15Sale4.0090,482361,9282,148,665Dec 15 09:00 PM
Castagna MichaelChief Executive OfficerDec 14Sale4.00110,000440,0002,239,147Dec 15 09:00 PM
Castagna MichaelChief Executive OfficerNov 01Sale4.2510,00042,5002,349,147Nov 02 09:00 PM
Castagna MichaelChief Executive OfficerOct 02Sale4.6110,00046,1002,359,147Oct 02 09:00 PM
Castagna MichaelChief Executive OfficerSep 01Sale4.6110,00046,1002,436,039Sep 05 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryAug 28Sale4.788,10038,738798,835Aug 28 09:00 PM
Castagna MichaelChief Executive OfficerAug 01Sale4.5710,00045,6862,496,735Aug 01 09:00 PM
Castagna MichaelChief Executive OfficerJul 03Sale4.0710,00040,7012,506,735Jul 05 06:00 AM
Castagna MichaelChief Executive OfficerJun 01Sale4.5310,00045,3022,516,735Jun 02 09:00 PM
Castagna MichaelChief Executive OfficerMay 26Sale4.5075,000337,3352,526,735May 26 09:00 PM
Castagna MichaelChief Executive OfficerMay 25Sale4.5975,000344,4682,601,735May 26 09:00 PM
Castagna MichaelChief Executive OfficerMay 24Sale4.69150,000702,7802,331,735May 24 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryMay 24Sale4.6895,576447,754735,263May 24 09:00 PM
Binder Steven B.Chief Financial OfficerMay 24Sale4.6747,810223,512838,324May 24 09:00 PM
Castagna MichaelChief Executive OfficerMay 05Sale4.0010,00040,0002,020,128May 05 09:00 PM
Castagna MichaelChief Executive OfficerApr 03Sale4.1310,00041,2872,030,128Apr 05 09:00 PM
Castagna MichaelChief Executive OfficerMar 01Sale5.2710,00052,7482,040,128Mar 03 09:00 PM